[1]
Zadvornyi, T. et al. 2023. EXPRESSION OF OSTEOPONTIN AND OSTEONECTIN IN BREAST AND PROSTATE CANCER CELLS WITH DIFFERENT SENSITIVITY TO DOXORUBICIN. Experimental Oncology. 44, 2 (May 2023), 107–112. DOI:https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17886.